Kura Oncology KURA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$294.57M-62.0% | -$278.67M-60.2% | -$216.88M-9.8% | -$197.17M-8.5% | -$181.89M-8.2% | ||
| $1.15M+34.0% | $1.03M+21.7% | $833K-2.9% | $877K+1.3% | $855K-2.5% | ||
| $37.68M+13.4% | $37.11M+9.5% | $34.39M+6.0% | $31.75M+1.8% | $33.23M+11.7% | ||
| —— | —— | $87.8M+152% | $124.99M+181% | $111.23M+181% | ||
| $6.47M+852% | $6.64M+1,306% | $4.69M+3,942% | $2.12M+1,460% | $680K+215% | ||
| —— | —— | —— | —— | —— | ||
| $1.72M-72.2% | $1.79M-98.8% | $1.46M-99.1% | $3.67M-97.6% | $6.19M— | ||
| —— | —— | —— | —— | $9.76M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kura Oncology generate?
- Kura Oncology (KURA) generated -$267.2M in operating cash flow over the trailing twelve months.
- What is Kura Oncology's free cash flow?
- After $6.5M of capital expenditures, Kura Oncology's free cash flow was -$271.6M over the trailing twelve months, down 302.9% year over year.
- Where does Kura Oncology's cash flow data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
